Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
The Medical Clinics of North America|October 18, 2005
Toxin-induced hyperthermic syndromesDaniel E Rusyniak, Jon E SpragueClinics in Laboratory Medicine|March 29, 2006
Hyperthermic syndromes induced by toxinsDaniel E Rusyniak, Jon E SpragueJournal of Molecular Medicine (Berlin, Germany)|December 17, 2004
The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamineEdward M Mills, Daniel E Rusyniak, Jon E SpragueBiochemical Pharmacology|September 4, 2004
UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermiaJon E Sprague, Nicole M Mallett, Daniel E Rusyniak, et al.The Journal of Emergency Medicine|February 26, 2014
Synthetic cathinones ("bath salts")Matthew L Banks, Travis J Worst, Daniel E Rusyniak, et al.British Journal of Pharmacology|May 26, 2004
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonistsJon E Sprague, Robert E Brutcher, Edward M Mills, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 3, 2004
The effects of ecstasy (MDMA) on rat liver bioenergeticsDaniel E Rusyniak, Stephany L Tandy, Lisa M Kamendulis, et al.Critical Care Medicine|June 9, 2005
Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal modelJon E Sprague, Petra Moze, David Caden, et al.The Psychiatric Clinics of North America|May 22, 2013
Neurologic manifestations of chronic methamphetamine abuseDaniel E RusyniakNeurologic Clinics|August 2, 2011
Neurologic manifestations of chronic methamphetamine abuseDaniel E RusyniakPageof 13